Welcome to the Dry AMD Therapeutics Summit

Finding new therapeutics to counter the progression of Dry AMD and prevent the geographical atrophy has never been more important. The aging population creates an ever-growing clinical need for next-generation therapeutics.

In 2020 there was an action-packed two-day agenda holds 22 Presentations from industry and academic leaders, a virtual poster session and 5+ hours of networking, you can join the only platform discussing issues present in the development of Dry AMD therapeutics.

Join this critical global forum united industry specialists from pharma, biotechs, academia and solution providers as we target the most pressing issues important to bringing the next generation of Dry AMD drugs to market

Expert Speakers at the 2020 Summit Included:

Christopher Brittain

Vice President & Global Head of Ophthalmology Product Development


David Schaffer

Co-Founder, Chief Scientific Officer & Co-Chairman of The Board of Directors

4D Molecular Therapeutics

Leonide Saad

President & CEO

Alkeus Pharmaceuticals, Inc.

Victor Chong

Global Head of Medicine, Retinal Health

Boehringer Ingelheim International GmbH

Jacque Duncan

Professor, Clinical Ophthalmology

University of California, San Francisco

Jane S. Lebkowski


Regenerative Patch Technologies

Qian Huang

Head of Ocular Inflammation, Ophthalmology


Reenie McCarthy


President & Chief Executive Officer Stealth BioTherapeutics Inc

2020 Partners 

Expertise Partner 

Expertise Partner 

Media Partner